Federal News & Issues

WASHINGTON, D.C., Oct. 16, 2020 – The American Psychiatric Association (APA) today announced that three of its members have been elected to leadership positions at the World Psychiatric Association (WPA). Two will join the Executive Committee for six-year terms as officers of the WPA: APA Past President Paul Summergrad, M.D., will serve as the WPA Secretary for Finances; and Edmond Pi, M.D., who previously served as the WPA USA Zone 2 Representative and vice chair of the APA Scientific Program Committee will serve as WPA Secretary for Scientific Meetings. Bernardo Ng, M.D., immediate past chair of the APA Council on International Psychiatry and Global Health was elected as the WPA Zone 2 (United States) Representative for a three-year term.

The WPA, a global association representing 140 psychiatric societies in 120 countries...

Read More
Author: mbourdase - Published: Oct 17, 2020

WASHINGTON, D.C., Oct. 7, 2020 – A new mobile app, My Mental Health Crisis Plan, allows individuals who have serious mental illness to create a plan to guide their treatment during a mental health crisis. The app was developed by SMI Adviser, an initiative administered by the American Psychiatric Association (APA) and funded by the Substance Abuse and Mental Health Services Administration (SAMHSA).

The app provides an easy step-by-step process for individuals to create and share a psychiatric advance directive (PAD). A PAD is a legal document that includes a list of instructions and preferences that the individual wishes to be followed in case of a mental health crisis. My Mental Health Crisis Plan allows individuals with serious mental illness to:

  • Clearly state treatment preferences, including...
Read More
Author: mbourdase - Published: Oct 7, 2020

Washington, D.C., Oct. 2, 2020 -The American Psychiatric Association (APA) today applauded the mental health and addiction-related resources included in the Heroes Act (H.R. 8406) passed by the U.S. House.  Evidence is mounting that the COVID-19 pandemic is exacerbating mental health conditions, while the economic consequences of the pandemic have been reducing the mental health and substance use treatment capacity across the country. The resources in the House-passed Heroes Act constitute a needed step toward treatment for mental illness and substance use disorders. The bill includes: 

  • $8.5 billion for the Substance Abuse and Mental Health Services Administration to fund state mental health and substance abuse block grants, trauma-informed care and other services and supports for schoolchildren, suicide prevention and...
Read More
Author: mbourdase - Published: Oct 5, 2020

WASHINGTON, D.C., Sept. 28, 2020 – The American Psychiatric Association (APA) is concerned about the impact a recent Trump Administration Executive Order may have on gender or racial diversity training in federal agencies and by contractors that receive federal funding.

The APA strongly supports education about diversity and inclusion. Diversity and inclusion training truly supports American values and empowers everyone with the skills and knowledge to create a diverse, inclusive and equitable working or learning environment. The goal of such training is to reduce prejudice and discrimination by helping us understand our uniqueness and abilities. The APA believes that all forms of racism, prejudice and discrimination affect mental health and well-being and negatively impact the nation. For this reason, diversity...

Read More
Author: mbourdase - Published: Sep 28, 2020

WASHINGTON, D.C., September 15, 2020 – The American Psychiatric Association Foundation (APAF), the philanthropic and educational arm of APA, joins a new public-private partnership launched today by the National Institute of Health (NIH) that is aimed at meeting the urgent need for early therapeutic interventions for people at risk of developing schizophrenia. It is part of the Accelerating Medicines Partnership (AMP) that promotes development of effective, targeted treatments.

AMP Schizophrenia brings together NIH, the Food and Drug Administration and multiple non-profit and private organizations. These partners will work to discover promising biological markers that can help identify people at risk of developing schizophrenia as early...

Read More
Author: mbourdase - Published: Sep 15, 2020



To advance the quality and effectiveness of psychiatric care through advocacy, professional education and camaraderie.



Contact Us

   (415) 334-2418
   (415) 239-2533
   77 Van Ness, Suite 101, #2022
San Francisco, CA 94102